DexCom, Inc. (DXCM)
-NasdaqGS 20.30 
0.03(0.15%) 25 May 04:00 SGT|After Hours
:
20.30 0.00 (0.02%) 25 May 04:35 SGT
| Prev Close: | 20.27 |
|---|
| Open: | 20.22 |
|---|
| Bid: | 1.24 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 18.32 |
|---|
| Beta: | 0.49 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 20.06 - 20.42 |
|---|
| 52wk Range: | 10.30 - 21.69 |
|---|
| Volume: | 332,520 |
|---|
| Avg Vol (3m): | 497,883 |
|---|
| Market Cap: | 1.44B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.74 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Nasdaq stocks posting largest percentage increasesAP(Sat, 06:04 SGT)
- DexCom Stays at NeutralZacks(Fri, 24 May)
- Medical Products Companies, Particularly Those Aimed at Surgical Procedures, Generating Substantial Free Cash and Showing High Returns on CapitalWall Street Transcript(Fri, 17 May)
- DexCom's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Fri, 17 May)
- 5 Stocks This Growth-Oriented Hedge Fund Is Most Committed Toat Seeking Alpha(Sun, 12 May)
- DexCom Announces Upcoming PresentationsBusiness Wire(Thu, 9 May)
- DEXCOM INC FinancialsEDGAR Online Financials(Thu, 9 May)
- 2 Winners and 3 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sun, 5 May)
- DexCom Loss Narrower than Est.Zacks(Fri, 3 May)
- DexCom's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, 2 May)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 13.10 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.56 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.16 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -1.14 |
|---|
Business Summary
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare provid...
View More